| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.5 | 0.0009 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.48 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.41 | 0.005 |